Download PDF
CC BY-NC-ND 4.0 · Horm Metab Res 2023; 55(09): 585-591
DOI: 10.1055/a-2142-4811
Original Article: Endocrine Care

Factors of Central Lymph Node Metastasis in Papillary Thyroid Cancer Based on C-TIRADS Analysis

Weijun Huang‡
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Deli Chen‡
2   Zhuhai Campus, Zunyi Medical University, Zunyi, China
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Minying Zhong
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Jieyi Ye
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Zhiyuan Zhi
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Yanyan Xiao
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
,
Yuan Zhong
1   Department of Ultrasound, First People’s Hospital of Foshan, Foshan, China
› Author Affiliations Funding Information Medical Scientific Research Foundation of Guangdong Province of China — B2021374; Project of Foshan “Fourteen Five” Medicine High-level Key Specialty Construction — FSGSP145037; Medical Scientific Research Foundation of Guangdong Province of China. — A2023502
› Further Information
Also available at
   Permissions and Reprints

Corrected by:

Correction: Factors of Central Lymph Node Metastasis in Papillary Thyroid Cancer Based on C-TIRADS AnalysisHorm Metab Res 2023; 55(09): e5-e5
DOI: 10.1055/a-2177-1891

Abstract

To study risk factors for central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC) using the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS). We retrospectively analysed patients who underwent PTC surgery and central lymph node dissection at First People’s Hospital of Foshan City. The clinical and ultrasonic data of the patients from 1150 cases were analysed by multivariate regression to evaluate the correlation between grayscale ultrasound (US) features, C-TIRADS score, and the classification of thyroid nodules and CLNM of PTCs. The C-TIRADS score was 3.0±1.0 in the CLNM group, which was higher than that in the non-CLNM group (p<0.001). Sex (male) (OR=1.586, 95% CI 1.232–2.042, p<0.001), age (≤45 years) (OR=1.508, 95% CI 1.184–1.919, p=0.001), location of nodes (lower pole) (OR=2.193, 95% CI 1.519–3.166, p<0.001), number (multifocal) (OR=2.204, 95% CI 1.227–2.378, p<0.001), microcalcification (OR=1.610, 95% CI 2.225–4.434, p=0.002), extrathyroidal extension (OR=2.204, 95% CI 1.941–3.843, p<0.001), maximum diameter of nodule (≥20 mm) (OR=3.211, 95% CI 2.337–4.411, p<0.001), and C-TIRADS score (OR=1.356, 95% CI 1.204–1.527, p<0.001) were PTC in independent risk factors for CLNM. The C-TIRADS score of PTC combined with the location, number, size, and ultrasound features of the lesion and the patient’s sex and age are important in predicting whether they present with CLNM and provide a reference basis for the clinical formulation of a reasonable surgical treatment plan.

Key words

papillary thyroid cancer - central lymph node metastasis - ultrasound - china thyroid imaging reporting and data system


Publication History

Received: 04 March 2023
Received: 17 July 2023

Accepted after revision: 27 July 2023

Accepted Manuscript online:
27 July 2023

Article published online:
07 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Bray F, Ferlay J, Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
    CrossrefPubMedGoogle Scholar
  • 2 Malterling RR, Andersson RE, Falkmer S. et al. Differentiated thyroid cancer in a Swedish county – long-term results and quality of life. Acta Oncol 2010; 49: 454-459
    CrossrefPubMedGoogle Scholar
  • 3 Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008; 144: 1070-1077 1077–1078
    CrossrefPubMedGoogle Scholar
  • 4 Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Amat Surgeon 2005; 71: 731-734
    CrossrefPubMedGoogle Scholar
  • 5 Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 2005; 6: 311-322
    CrossrefPubMedGoogle Scholar
  • 6 Yang Z, Yin L, Zeng Y. et al. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma. Virchows Arch 2021; 479: 947-959
    CrossrefPubMedGoogle Scholar
  • 7 Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer-AM Cancer Soc 2006; 106: 524-531
    PubMedGoogle Scholar
  • 8 Zhang L, Wei WJ, Ji QH. et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocr Metab 2012; 97: 1250-1257
    CrossrefPubMedGoogle Scholar
  • 9 Feng JW, Qu Z, Ye J. et al. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma. Surgery 2021; 170: 1670-1679
    CrossrefPubMedGoogle Scholar
  • 10 Haugen BR, Alexander EK, Bible KC. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133
    CrossrefPubMedGoogle Scholar
  • 11 Takami H, Ito Y, Okamoto T, Yoshida A. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese society of thyroid surgeons and Japanese association of endocrine surgeons. World J Surg 2011; 35: 111-121
    CrossrefPubMedGoogle Scholar
  • 12 Kwak JY, Han KH, Yoon JH. et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011; 260: 92-899
    PubMedGoogle Scholar
  • 13 Superficial Organ and Vascular Group, Society of Ultrasound in Medicine, Chinese Medical Association, 2020. Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Chin J Ultrasonogr 2021; 185-200
    PubMedGoogle Scholar
  • 14 Liu C, Zhang L, Wang X. Risk factors of cervical lymph nodule metastasis on papillary thyroid carcinoma based on C-TIRADS. J Practl Med 2021; 37: 1587-1591
    PubMedGoogle Scholar
  • 15 Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 2011; 121: 487-491
    CrossrefPubMedGoogle Scholar
  • 16 Kim SK, Woo JW, Park I. et al. Computed tomography-detected central lymph node metastasis in ultrasonography node-negative papillary thyroid carcinoma: is it really significant?. Ann Surg Oncol 2017; 24: 442-449
    CrossrefPubMedGoogle Scholar
  • 17 Deng Y, Zhang J, Wang J. et al. Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics. Postgrad Med 2022; 1-7
    PubMedGoogle Scholar
  • 18 Zhou B, Wei L, Qin J. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage. Adian J Surg 2021; 44: 1357-1362
    PubMedGoogle Scholar
  • 19 Feng JW, Yang XH, Wu BQ. et al. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin Transl Oncol 2019; 21: 1482-1491
    PubMedGoogle Scholar
  • 20 Zhou B, Qin J. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma (cT1N0). Eur J Surg Oncol 2021; 47: 882-887
    CrossrefPubMedGoogle Scholar
  • 21 Sun W, Lan X, Zhang H. et al. Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: a systematic review and meta-analysis. Plos One 2015; 10: e139021
    PubMedGoogle Scholar
  • 22 Calò PG, Conzo G, Raffaelli M. et al. Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study. Eur J Surg Oncol 2017; 43: 126-132
    CrossrefPubMedGoogle Scholar
  • 23 Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer 2014; 21: T273-T283
    CrossrefPubMedGoogle Scholar
  • 24 Wang Z, Chang Q, Zhang H. et al. A clinical predictive model of entral lymph node metastases in papillary thyroid carcinoma. Front Endocrinol 2022; 13: 856278
    CrossrefPubMedGoogle Scholar
  • 25 Shukla N, Osazuwa-Peters N, Megwalu UC. Association between age and nodal metastasis in papillary thyroid carcinoma. Otolaryngol Head Neck 2021; 165: 43-49
    CrossrefPubMedGoogle Scholar
  • 26 Feng JW, Yang XH, Wu BQ. et al. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin Transl Oncol 2019; 21: 1482-1491
    CrossrefPubMedGoogle Scholar
  • 27 Mao J, Zhang Q, Zhang H. et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front Endocrinol 2020; 11: 265
    CrossrefPubMedGoogle Scholar
  • 28 Hoang JK, Middleton WD, Farjat AE. et al. Reduction in thyroid nodule biopsies and improved accuracy with American college of radiology thyroid imaging reporting and data system. Radiology 2018; 287: 185-193
    CrossrefPubMedGoogle Scholar
  • 29 Delfim R, Veiga L, Vidal A. et al. Likelihood of malignancy in thyroid nodules according to a proposed Thyroid Imaging Reporting and Data System (TI-RADS) classification merging suspicious and benign ultrasound features. Arch Endocr Metab 2017; 61: 211-221
    CrossrefPubMedGoogle Scholar
  • 30 Zhao YZ, He NA, Ye XJ. et al. Analysis of risk factors associated with central lymph node metastasis in papillary thyroid carcinoma with cT1N0 Stage. Front Endocrinol 2022; 13: 880911
    CrossrefPubMedGoogle Scholar
  • 31 Feng JW, Qu Z, Qin AC. et al. Significance of multifocality in papillary thyroid carcinoma. Eur J Surg Oncol 2020; 46: 1820-1828
    CrossrefPubMedGoogle Scholar
  • 32 Jiang LH, Yin KX, Wen QL. et al. Predictive risk-scoring model for central lymph node metastasis and predictors of recurrence in papillary thyroid carcinoma. Sci Rep-UK 2020; 10: 710
    CrossrefPubMedGoogle Scholar
  • 33 Feng JW, Ye J, Wu WX. et al. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence. J Endocrinol Invest 2020; 43: 1807-1817
    CrossrefPubMedGoogle Scholar
  • 34 Bai Y, Zhou G, Nakamura M. et al. Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Modern Pathol 2009; 22: 887-894
    CrossrefPubMedGoogle Scholar
  • 35 Deng S, Li Q, Chen S. et al. Analysis of related factors on cervical lymph node metastasis and ultrasonographic characteristics of papillary thyroid microcarcinoma. J Clin Ultrasound Med 2017; 19: 424-426
    PubMedGoogle Scholar
  • 36 Shi C, Li S, Shi T. et al. Correlation between thyroid nodule calcification morphology on ultrasound and thyroid carcinoma. J Int Med Res 2012; 40: 350-357
    CrossrefPubMedGoogle Scholar
  • 37 Zhou L, Yao J, Ou D. et al. A multi-institutional study of association of sonographic characteristics with cervical lymph node metastasis in unifocal papillary thyroid carcinoma. Front Endocrinol 2022; 13: 965241
    CrossrefPubMedGoogle Scholar
  • 38 Arora N, Turbendian HK, Scognamiglio T. et al Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery 2008; 144: 942-947 947–948
    CrossrefPubMedGoogle Scholar
  • 39 Abuduwaili M, Su A, Xing Z. et al. Clinical significance of extrathyroidal extension to major vessels in papillary thyroid carcinoma. J Endocrinol Invest 2022; 46: 1155-1167
    CrossrefPubMedGoogle Scholar
  • 40 Yan B, Hou Y, Chen D, He J, Jiang Y. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis. Int J Surg 2018; 59: 90-98
    CrossrefPubMedGoogle Scholar
  • 41 Park HM, Lee J, Kwak JY. et al. Using ultrasonographic features to predict the outcomes of patients with small papillary thyroid carcinomas: a retrospective study implementing the 2015 ATA patterns and ACR TI-RADS categories. Ultrasonography 2022; 41: 298-306
    CrossrefPubMedGoogle Scholar
  • 42 Liu C, Zhang L, Wang X. Risk factors of cervical lymph nodule metastasis on papillary thyroid carcinoma based on C-TIRADS. J Practl Med 2021; 37: 1587-1591
    PubMedGoogle Scholar